Similar articles

• Reasons for Discontinuation and Adverse Effects of TNFα Inhibitors in a Cohort of Patients With Rheumatoid Arthritis and Ankylosing Spondylitis.

  García-Lagunar MH, Gutiérrez-Cívicos MR, García-Simón MS, Conesa-Zamora P, Jimenez-Santos E, Cano-Vivar P, García-Márquez A, Muñoz-García I, Viney AC. García-Lagunar MH, et al. Ann Pharmacother. 2017 May;51(5):388-393. doi: 10.1177/1060028016682330. Epub 2016 Dec 5. Ann Pharmacother. 2017. PMID: 27920336
• Small-Fiber Neuropathy in a Pediatric Patient Following Anti-Tumor Necrosis Factor-α Therapy for Ulcerative Colitis.

  Breton J, Ellazam B, Haddad E, Deslandres C. Breton J, et al. J Pediatr Gastroenterol Nutr. 2018 Jun;66(6):e159-e161. doi: 10.1097/MPG.0000000000001992. J Pediatr Gastroenterol Nutr. 2018. PMID: 29620599 No abstract available.
• Do Anti-TNF Agents Increase the Risk of Inflammatory Bowel Disease Evolution in Patients with Ankylosing Spondylitis? Real Life Data.

  Üsküdar Cansu D, Üsküdar Teke H, Temel T, Ertürk A, Kahraman O, Korkmaz C. Üsküdar Cansu D, et al. J Natl Med Assoc. 2019 Jun;111(3):262-269. doi: 10.1016/j.jnma.2018.10.003. Epub 2018 Oct 30. J Natl Med Assoc. 2019. PMID: 30389147
• Is secukinumab a safe alternative treatment for ankylosing spondylitis with Guillain Barré syndrome after anti-TNF-α treatment? Case report and literature review.

  Psarelis S, Hajineocli APD, Hadjicosta E, Elliott HSA, Johnson P. Psarelis S, et al. Clin Rheumatol. 2017 May;36(5):1197-1199. doi: 10.1007/s10067-017-3573-1. Epub 2017 Feb 23. Clin Rheumatol. 2017. PMID: 28233109 Review.
• Invasive fungal infections in pediatric patients treated with tumor necrosis alpha (TNF-α) inhibitors.

  Tragiannidis A, Kyriakidis I, Zündorf I, Groll AH. Tragiannidis A, et al. Mycoses. 2017 Apr;60(4):222-229. doi: 10.1111/myc.12576. Epub 2016 Oct 21. Mycoses. 2017. PMID: 27766695 Review.